CN109496215A - 一种福沙匹坦磷酸酯中间体及其制备方法 - Google Patents

一种福沙匹坦磷酸酯中间体及其制备方法 Download PDF

Info

Publication number
CN109496215A
CN109496215A CN201780021165.9A CN201780021165A CN109496215A CN 109496215 A CN109496215 A CN 109496215A CN 201780021165 A CN201780021165 A CN 201780021165A CN 109496215 A CN109496215 A CN 109496215A
Authority
CN
China
Prior art keywords
fosaprepitant
methods according
item
alkali
phosphate intermediate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201780021165.9A
Other languages
English (en)
Other versions
CN109496215B (zh
Inventor
张继承
栗增
黄鲁宁
陈茜
陶安平
顾虹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Aobo Biomedical Co ltd
Zhejiang Huahai Pharmaceutical Co Ltd
Original Assignee
Zhejiang Huahai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Huahai Pharmaceutical Co Ltd filed Critical Zhejiang Huahai Pharmaceutical Co Ltd
Publication of CN109496215A publication Critical patent/CN109496215A/zh
Application granted granted Critical
Publication of CN109496215B publication Critical patent/CN109496215B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

提供一种福沙匹坦磷酸酯中间体(IV)的制备方法、福沙匹坦磷酸酯中间体(IV‑A)以及使用中间体(IV‑A)制备福沙匹坦二甲葡胺的方法(AA)，IV：R1、R2独立地选自C1‑C7烷基或苄基；IV‑A：R1、R2独立地选自C1‑C7烷基或苄基，并且R1、R2不同时为苄基

Description

PCT国内申请，说明书已公开。

Claims (22)

  1. PCT国内申请，权利要求书已公开。
CN201780021165.9A 2016-05-09 2017-05-09 一种福沙匹坦磷酸酯中间体及其制备方法 Active CN109496215B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2016103008907 2016-05-09
CN201610300890.7A CN107353303B (zh) 2016-05-09 2016-05-09 一种福沙匹坦磷酸酯中间体的制备方法
PCT/CN2017/083630 WO2017193913A1 (zh) 2016-05-09 2017-05-09 一种福沙匹坦磷酸酯中间体及其制备方法

Publications (2)

Publication Number Publication Date
CN109496215A true CN109496215A (zh) 2019-03-19
CN109496215B CN109496215B (zh) 2021-07-23

Family

ID=60267878

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201610300890.7A Active CN107353303B (zh) 2016-05-09 2016-05-09 一种福沙匹坦磷酸酯中间体的制备方法
CN201780021165.9A Active CN109496215B (zh) 2016-05-09 2017-05-09 一种福沙匹坦磷酸酯中间体及其制备方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201610300890.7A Active CN107353303B (zh) 2016-05-09 2016-05-09 一种福沙匹坦磷酸酯中间体的制备方法

Country Status (4)

Country Link
US (1) US11091508B2 (zh)
EP (1) EP3456726B1 (zh)
CN (2) CN107353303B (zh)
WO (1) WO2017193913A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045605B (zh) * 2021-03-30 2022-06-07 浙江亚瑟医药有限公司 一种福沙匹坦二甲葡胺的制备方法和纯化方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010018595A2 (en) * 2008-07-17 2010-02-18 Glenmark Generics Limited Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations
WO2011163594A2 (en) * 2010-06-24 2011-12-29 Alkermes, Inc. Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
WO2013168176A2 (en) * 2012-03-30 2013-11-14 Glenmark Generics Limited Process for preparation of fosaprepitant and salt thereof
CN104098604A (zh) * 2013-04-10 2014-10-15 山东省生物药物研究院 一种制备福沙匹坦二甲葡胺的方法
CN104650142A (zh) * 2013-11-25 2015-05-27 山东新时代药业有限公司 一种福沙匹坦二甲葡胺的制备方法
CN106432337A (zh) * 2015-08-08 2017-02-22 陕西合成药业股份有限公司 福沙匹坦衍生物、合成和在长效制剂中的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW385308B (en) 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
WO2011045817A2 (en) 2009-10-15 2011-04-21 Sandoz Private Limited Process for the preparation of fosaprepitant, intermediate and pharmaceutical acceptable salt thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010018595A2 (en) * 2008-07-17 2010-02-18 Glenmark Generics Limited Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations
WO2011163594A2 (en) * 2010-06-24 2011-12-29 Alkermes, Inc. Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
US9072788B2 (en) * 2010-06-24 2015-07-07 Alkermes Pharma Ireland Limited Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
WO2013168176A2 (en) * 2012-03-30 2013-11-14 Glenmark Generics Limited Process for preparation of fosaprepitant and salt thereof
CN104098604A (zh) * 2013-04-10 2014-10-15 山东省生物药物研究院 一种制备福沙匹坦二甲葡胺的方法
CN104650142A (zh) * 2013-11-25 2015-05-27 山东新时代药业有限公司 一种福沙匹坦二甲葡胺的制备方法
CN106432337A (zh) * 2015-08-08 2017-02-22 陕西合成药业股份有限公司 福沙匹坦衍生物、合成和在长效制剂中的用途

Also Published As

Publication number Publication date
EP3456726A1 (en) 2019-03-20
EP3456726A4 (en) 2019-12-11
CN107353303B (zh) 2020-09-01
CN109496215B (zh) 2021-07-23
EP3456726B1 (en) 2020-12-02
CN107353303A (zh) 2017-11-17
US11091508B2 (en) 2021-08-17
WO2017193913A1 (zh) 2017-11-16
US20190144477A1 (en) 2019-05-16

Similar Documents

Publication Publication Date Title
CN102753537B (zh) 制备利伐沙班的方法
CN108314639B (zh) 化合物（e）-3-（1-甲基吡咯烷-2-基）-丙烯酸盐酸盐及合成方法
CN104610360A (zh) 一种富马酸替诺福韦二吡呋酯的制备方法
CN102143967B (zh) 阿德福韦酯的纯化方法
KR20150072408A (ko) 5-(2,6-디-4-모르폴리닐-4-피리미디닐)-4-트리플루오로메틸피리딘-2-아민의 개선된 제조 방법
CN109438405A (zh) 一种3-(苄氧基)-4-氧代-4h-吡喃-2-羧酸的合成方法
ITMI20121390A1 (it) Procedimento per la preparazione di acido 2-cianofenilboronico e suoi esteri, intermedi del perampanel o di e2040
CN103025715A (zh) 用于制备凝血酶特异性抑制剂的中间体和方法
CN109496215A (zh) 一种福沙匹坦磷酸酯中间体及其制备方法
RU2326885C1 (ru) Способ получения диизопропил ((1-(гидроксиметил)-циклопропил)окси) метилфосфоната
CN102731368B (zh) 一种5,5-二氟-3-取代哌啶衍生物的制备方法
ES2525690T3 (es) Procedimiento para la preparación de 2-alcoxi-5-(piridin-2-il)piridina, un intermediario de perampanel
CN104974051A (zh) (1S,4R)-cis-4-氨基-2-环戊烯-1-甲醇盐酸盐的合成方法
KR100663167B1 (ko) 염산 이토프리드의 제조방법
CN104098604B (zh) 一种制备福沙匹坦二甲葡胺的方法
CN108948080B (zh) 一种福沙匹坦药用盐的制备方法
CN101492431B (zh) 马来酸桂哌齐特的制备方法
CN105330612B (zh) 2‑(5‑氨基‑1,2,4‑噻二唑‑3‑基)‑2‑甲氧亚氨基乙酸的合成工艺
JP7176104B2 (ja) ベンゾアゼピン化合物の製造方法
CN104650143B (zh) 制备福沙匹坦二甲葡胺中间体的方法
CN106432182B (zh) 特地唑胺中间体的合成方法
JP2019507189A (ja) ポサコナゾール、組成物、中間体、並びにその製造方法及び使用
CN111153856A (zh) 盐酸法舒地尔具有基因毒性的杂质制备方法
US692437A (en) Hydrochlorid of cinnamyl-quinin and process of making same.
WO2020020370A1 (zh) 三甲铵基乙硫磷酰二乙酯碘化物的制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: 317024 Flood Bridge, Linhai City, Taizhou City, Zhejiang Province

Patentee after: ZHEJIANG HUAHAI PHARMACEUTICAL Co.,Ltd.

Patentee after: Shanghai Aobo biomedical Co.,Ltd.

Address before: 317024 Flood Bridge, Linhai City, Taizhou City, Zhejiang Province

Patentee before: ZHEJIANG HUAHAI PHARMACEUTICAL Co.,Ltd.

Patentee before: SHANGHAI AOBO PHARMTECH, Inc.,Ltd.

CP01 Change in the name or title of a patent holder